The mechanism through which this SNP might influence breast cancer risk is unclear, although studies in transgenic mice have demonstrated that activation or overexpression of the HER2 gene leads to the development of mammary adenocarcinomas [19-21]. The gene discussed is ERBB2; the disease is breast adenocarcinoma.